Clinical trial
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
NCT00158262 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00158262 |
|---|---|
| Title | Effect of Propranolol on Preventing Posttraumatic Stress Disorder |
| Official title | Prophylaxis of Posttraumatic Stress Disorder With Post-Trauma Propranolol |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post-Traumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | Propranolol, Placebo |
| Enrollment | 43 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: